|
|
|
|
|
|
|
|
|
|
Super Quote | Detail Quote | Interactive Chart | Transaction | Related News | Related Securities | Company Information | Dividend Records | Short Sell
02186 LUYE PHARMA
Nominal 
3.660 -0.150 (-3.937%) | 2025/06 - Interim RMB(K¥) | %Chg (Compare to Interim) | 2024/06 RMB(K¥) | 2023/06 RMB(K¥) | 2022/06 RMB(K¥) | 2021/06 RMB(K¥) | |
| Turnover | 3,181,110 | 3.465% | 3,074,582 | 2,904,108 | 2,850,826 | 2,951,664 |
| Cost of Sales | (1,023,501) | 2.758% | (996,032) | (960,745) | (800,742) | (997,983) |
| Gross Profit | 2,157,609 | 3.804% | 2,078,550 | 1,943,363 | 2,050,084 | 1,953,681 |
| 2025/06 - Interim RMB(K¥) | %Chg (Compare to Interim) | 2024/06 RMB(K¥) | 2023/06 RMB(K¥) | 2022/06 RMB(K¥) | 2021/06 RMB(K¥) | ||
| Change in FV & Impairment on Inv. Prop. | -- | -- | -- | -- | -- | -- | |
| Change in FV & Impairment on Others | -- | -- | -- | -- | -- | -- | |
| Profit / (Loss) on Disposal | -- | -- | -- | -- | -- | -- | |
| Other Non-operating Items | -- | -- | -- | -- | -- | -- | |
| Share of Results of Asso. & JCEs | (12,022) | -- | 345 | 232 | 568 | 358 | |
| Profit / (Loss) before Taxation | 457,640 | -13.649% | 529,977 | 228,988 | 375,373 | 488,436 | |
| Taxation | (100,257) | 9.214% | (91,799) | (83,634) | (72,187) | (80,446) | |
| Profit / (Loss) from Discontinued Operations | -- | -- | -- | -- | -- | -- | |
| Non-controlling Interests | (44,497) | -11.611% | (50,342) | 4,623 | (6,189) | (21,405) | |
| Others | -- | -- | -- | -- | -- | -- | |
| Profit / (Loss) Attributable to Shareholders | 312,886 | -19.325% | 387,836 | 149,977 | 296,997 | 386,585 | |
| 2025/06 - Interim RMB(K¥) | %Chg (Compare to Interim) | 2024/06 RMB(K¥) | 2023/06 RMB(K¥) | 2022/06 RMB(K¥) | 2021/06 RMB(K¥) | |
| Net Finance Costs / (Income) | 338,460 | 44.558% | 234,134 | 255,565 | 168,666 | 140,890 |
| Depreciation & Amortisation | 408,138 | 17.178% | 348,305 | 331,431 | 326,472 | 270,260 |
| Directors' Emoluments | -- | -- | -- | -- | -- | -- |
| 2025/06 - Interim | %Chg (Compare to Interim) | 2024/06 | 2023/06 | 2022/06 | 2021/06 | |
| Auditor's Opinion Status | N/A | -- | N/A | N/A | N/A | N/A |
Market Valuation Indicators
| 2025/06 - Interim | %Chg (Compare to Interim) | 2024/06 | 2023/06 | 2022/06 | 2021/06 | |
| EPS (cts) | 8.320 | -19.302% | 10.310 | 4.060 | 8.540 | 11.320 |
| DPS (cts) | 0.000 | -- | 0.000 | 0.000 | 0.000 | 0.000 |
| Dividend Payout Ratio (%) | -- | -- | -- | -- | -- | -- |
| Cash flow per share ($) | -- | -- | -- | -- | -- | -- |
| NBV per share ($) | 3.906 | -- | 3.461 | 3.013 | 2.403 | 2.498 |
| Remarks: | Real time quote last updated: 10/09/2025 12:08 |
| Real-time basic market prices of Hong Kong securities are provided by HKEx; a Designated Website authorized by the HKEx Group to provide the Service. | |
| Profit / (Loss) Attributable to Shareholders (K¥) | RMB 312,886 |
| %Change | -19.325% |
| EPS / (LPS) | RMB 0.083 |
| NBV Per Share (¥) | RMB 3.906 |